Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 29 (KRT18P29) is one of many processed pseudogenes derived from the keratin 18 gene and is dispersed throughout the human genome[3]. Pseudogenes are typically nonfunctional DNA segments that resemble known genes but do not produce functional proteins, and KRT18P29 does not have an intact reading frame or known biological activity[3]. There is no evidence that KRT18P29 acts as a therapeutic target, nor is it associated with disease processes or drug interaction pathways. KRT18P29 should not be confused with the functional keratin 18 gene (KRT18), which encodes a type I cytokeratin involved in epithelial cell structure and is a widely studied biomarker in cancer and tissue pathology[1][2][4][7]. KRT18P29 is a noncoding, nonfunctional pseudogene and not suitable as a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 29 (KRT18P29).